Zydus and WHO to develop MAbs against rabies
This article was originally published in Scrip
Executive Summary
Zydus Cadilahas signed an agreement with the World Health Organization(WHO) to explore a collaboration to develop a cocktail therapy for the treatment of rabies, using monoclonal antibodies (MAbs).